Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 DaVita Expands Central Lab Services | Contract Pharma

What are you searching for?

Sign in
Breaking News

DaVita Expands Central Lab Services

Increases test menu by 43%

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

DaVita Clinical Research (DCR) is expanding its Central Laboratory services. The company’s test menu will increase by 43%, maintaining its position in advanced renal care as well as coverage in the areas of oncology, immunology, endocrinology, cardiology and anemia. DCR’s Central Lab is focused on providing clinical research in both complex/specialty populations and therapeutic areas, as well as chronic kidney disease (CKD) populations.  

The testing facility has added two new testing platforms, the Immulite 2000 XPi Immunoassay System and the AB Sciex QTrap 5500 LC/MS/MS system. Other additions include increased specimen management and storage capabilities for short- and long-term testing. The Central Lab facilities have also made continuous IT advancements for clean, timely data and customer access to lab results.

“We are proud of our recent investments in equipment and assay development,” stated DCR vice president of Commercial Development Kevin J. Goudreau. “These investments will allow us to supply central laboratory services outside of renal care. We will continue to invest heavily in assay development until the breadth of our offering covers virtually all therapeutic indications.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters